#Ireland #Dublin #LUMA Vision #VERAFEYE #4D Imaging

LUMA Vision to Unveil Revolutionary VERAFEYE 4D Imaging Platform at HRS 2026

LUMA Vision, a foremost innovator in real-time 4D cardiac imaging and navigation, is poised to make a significant impact at the upcoming Heart Rhythm Society Annual Meeting (HRS 2026) in Chicago. The company will showcase its advanced VERAFEYE™ Visualization and Guidance Platform, which promises to set a new standard in electrophysiology (EP) guidance.

At HRS 2026, clinical professionals will have the opportunity to experience firsthand how the VERAFEYE system enables seamless real-time visualization of cardiac anatomy and catheter positioning during procedures. This innovative approach marks a significant advancement over traditional imaging and mapping techniques, which have often been limited and fragmented.

The VERAFEYE platform uniquely combines live 2D and 4D intra-procedural imaging with highly accurate digital anatomical models, delivering clarity and precision rivaling that of CT scans within mere seconds. This revolutionary capability supports faster decision-making and more intuitive procedural workflows.

Redefining EP Guidance

The VERAFEYE system aims to redefine how electrophysiology procedures are conducted. By serving as an integrated platform rather than merely a tool, VERAFEYE seeks to streamline current EP workflows, which are typically reliant on three separate systems: point-by-point mapping, intracardiac echocardiography (ICE), and fluoroscopy. This integration allows physicians to visualize and guide therapies in real-time, enhancing procedural outcomes.

Some notable features of VERAFEYE include:

• - Single-operator efficiency: Streamlined workflows enabling a single medical professional to conduct intricate procedures effectively.
• - Support for various technologies: The system is compatible with multiple ablation technologies, providing flexibility in treatment options.
• - Reduction in fluoroscopy: By minimizing reliance on fluoroscopic imaging, patient exposure to radiation is reduced significantly.
• - True dual-catheter procedure: This unique feature allows for greater precision and efficiency during procedures.

Highlights from HRS 2026

LUMA Vision's presence at HRS 2026 will not go unmissed, with several scheduled presentations:

• - April 22, 3:00 PM, Embassy Suites by Hilton Chicago: Dr. Shephal Doshi will explain how real-time 4D imaging is ushering in innovations in EP technology.
• - April 23, 5:00 PM, McCormick Place Convention Center: Dr. Vivek Reddy will demonstrate the VERAFEYE System's capabilities during a large-focal PFA catheter guidance case.
• - April 25, 12:00 PM - 2:00 PM, Abstract Pavilion: Dr. Toni Breskovic will present compelling clinical data validating the workflow and procedural advantages of VERAFEYE.

Fionn Lahart, the CEO of LUMA Vision, remarked, "This marks a transformative moment for both LUMA Vision and the future of cardiac procedures. VERAFEYE represents a globally unique, AI-powered system that redefines how interventions are performed, offering a cohesive real-time view of the heart. As we move towards next-generation ablation technologies, guidance will become indispensable, serving as the AI-enabled platform that will support all other methodologies."

LUMA Vision's innovative technology leverages sophisticated AI algorithms to instantly interpret cardiac anatomy, thereby establishing a unified framework that spans numerous procedural applications. This intelligent base facilitates greater accuracy, improved workflows, and enhanced integration across the entire cardiac ecosystem.

Meet Us at HRS 2026

Attendees of HRS 2026 are invited to visit Booth #2415 to interact with LUMA Vision's clinical team and discover how VERAFEYE delivers CT-quality digital anatomy rapidly, revolutionizing precision and control in electrophysiology procedures. As the field advances towards platform-driven workflows, VERAFEYE is well-positioned to establish itself as a cornerstone imaging layer that integrates seamlessly across various mapping systems.

About LUMA Vision

LUMA Vision operates out of Dublin, Ireland, with significant operations in Munich, Germany. The company focuses on designing next-generation cardiac visualization and navigation systems, which significantly enhance clinicians' capability to treat patients with unmatched precision. VERAFEYE stands as LUMA Vision's flagship platform, providing a comprehensive, real-time view inside the heart, thereby redefining accuracy in electrophysiological and structural heart interventions. Founded by Fionn Lahart and Christoph Hennersperger, LUMA Vision is dedicated to innovating cardiac care, improving patient outcomes and saving lives.